Altimmune (ALT) EBT Margin: 2010-2025
Historic EBT Margin for Altimmune (ALT) over the last 16 years, with Sep 2025 value amounting to -380,280.00%.
- Altimmune's EBT Margin rose 7662000.00% to -380,280.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -423,570.00%, marking a year-over-year decrease of 22449308.00%. This contributed to the annual value of -475,535.00% for FY2024, which is 45477279.00% down from last year.
- Latest data reveals that Altimmune reported EBT Margin of -380,280.00% as of Q3 2025, which was up 14.14% from -442,920.00% recorded in Q2 2025.
- In the past 5 years, Altimmune's EBT Margin ranged from a high of -728.99% in Q4 2021 and a low of -1,185,650.00% during Q3 2022.
- Over the past 3 years, Altimmune's median EBT Margin value was -405,120.00% (recorded in 2025), while the average stood at -326,212.19%.
- Its EBT Margin has fluctuated over the past 5 years, first plummeted by 116,444,114bps in 2022, then surged by 117,993,978bps in 2023.
- Altimmune's EBT Margin (Quarterly) stood at -728.99% in 2021, then slumped by 8,257,870bps to -83,307.69% in 2022, then plummeted by 220,852bps to -85,516.22% in 2023, then tumbled by 38,044,378bps to -465,960.00% in 2024, then soared by 7,662,000bps to -380,280.00% in 2025.
- Its EBT Margin was -380,280.00% in Q3 2025, compared to -442,920.00% in Q2 2025 and -405,120.00% in Q1 2025.